Zimmer Biomet Holdings, Inc. Profile Avatar - Palmy Investing

Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstru…
Medical - Devices
US, Warsaw [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
75.81 76.01 74.80 74.84 72.18 73.26 69.05 69.09 72.74 71.36 71.78 69.70 71.29 70.90 63.06
Profit Margin
17.52 14.14 17.09 16.88 16.46 15.41 0.83 3.94 23.51 -4.78 14.18 -1.96 5.88 3.33 13.85
Operating Margin
24.88 21.72 23.00 23.42 22.40 22.14 5.44 10.77 10.52 0.43 14.25 10.30 12.60 15.33 18.76
EPS Growth
-10.46 -10.78 36.24 6.40 3.94 -5.12 -93.66 459.26 503.31 -120.42 396.77 -111.96 392.42 -27.98 253.24
Return on Assets (ROA)
9.21 7.46 8.93 8.38 7.94 7.47 0.18 1.14 6.97 -1.57 4.59 -0.56 1.71 1.10 4.76
Return on Equity (ROE)
12.72 10.34 13.80 12.87 12.08 11.04 0.51 3.16 15.65 -3.36 9.13 -1.13 3.17 1.92 8.20
Return on Invested Capital (ROIC)
10.82 9.20 10.99 10.36 10.05 9.92 6.07 2.99 14.41 0.23 6.89 1.78 3.89 4.33 7.28
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
14.48 14.28 20.19 20.20 17.46 14.80 42.16 42.42 38.43 37.05 33.37 33.28 30.18 27.04 27.08
Debt/Equity
20.00 19.79 31.18 31.04 26.55 21.86 117.78 117.35 86.26 79.27 66.34 66.61 55.92 47.39 46.64
Debt/EBITDA
26.37 27.29 65.17 55.34 35.39 24.71 521.99 439.30 344.41 385.95 334.79 417.11 342.72 267.31 238.57
Debt/Capitalization
16.66 16.52 23.77 23.69 20.98 17.94 54.08 53.99 46.31 44.22 39.88 39.98 35.86 32.15 31.81
Interest Debt per Share USD
5.15 5.43 9.41 10.83 10.28 8.81 63.20 58.02 51.86 45.36 41.19 40.28 34.94 27.96 28.83
Debt Growth
145.08 1.29 50.54 5.91 -8.13 -14.78 710.68 -2.69 -9.81 -11.87 -8.03 -1.15 -12.89 -19.53 5.24
Liquidity
Current Ratio
396.41 428.32 377.88 428.26 406.91 413.20 368.81 194.65 152.45 184.76 137.26 198.81 140.86 187.74 161.32
Quick Ratio
264.20 295.14 270.65 313.33 302.75 300.58 227.79 112.63 83.19 90.59 67.96 102.96 78.92 96.69 77.84
Cash Ratio
100.14 95.24 88.61 102.11 104.75 104.36 88.81 26.41 17.45 22.65 17.95 31.37 10.90 15.93 14.55
Operating Cash Flow Ratio
100 100 100 100 - - 100 - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
108.50 108.24 120.67 113.05 119.69 106.91 80.49 120.60 102.46 100.68 94.45 86.85 91.27 94.05 114.51
Receivables Turnover
545.04 544.05 530.73 505.51 493.64 512.37 412.73 478.93 523.49 621.80 585.25 483.55 542.02 502.35 512.63
Payables Turnover
736.11 781.17 782.97 611.19 879.08 747.94 651.90 651.55 645.94 626.56 561.89 644.94 639.61 570.32 719.12
Asset Turnover
52.60 52.77 52.28 49.62 48.26 48.50 21.88 28.99 29.65 32.88 32.40 28.77 29.11 32.94 34.40
Coverage
Interest Coverage
-4,945.63 -1,622.48 2,265.71 1,436.76 1,477.32 1,639.78 113.89 231.32 251.36 11.55 501.32 341.18 412.81 645.69 710.19
Asset Coverage
500 500 400 400 400 500 100 100 100 100 100 100 200 200 200
Cash Flow Coverage (CFGR)
99.10 104.50 68.45 63.26 57.57 73.85 7.47 14.51 15.60 19.55 19.29 14.82 21.18 22.55 27.17
EBITDA Coverage
-8,000 -3,000 3,200 2,300 2,300 2,100 600 600 800 700 1,000 800 900 1,200 1,100
Dividend Coverage
- - - - -100 -700 -500 -400 - - -100 -900 100 -500 - - -200 -100 -500
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
- - - - 5.25 0.83 0.86 0.78 0.84 0.94 0.82 0.95 0.66 0.64 0.78 0.75 0.79
Earnings Yield
5.82 5.73 7.83 6.68 4.96 3.87 0.27 1.51 7.78 -1.85 3.80 -0.44 1.56 0.87 4.03
Price/Earnings (P/E)
1,718.44 1,745.02 1,277.79 1,498.12 2,014.92 2,582.29 37,525.25 6,610.76 1,284.76 -5,399.83 2,631.90 -22,521.42 6,401.36 11,548.83 2,480.35
Price/Book (P/B)
218.63 180.48 176.28 192.81 243.39 285.17 190.08 208.96 201.01 181.59 240.32 253.66 203.05 222.31 203.51
Price/Sales (P/S)
301.02 246.81 218.37 252.94 331.65 397.90 310.95 260.60 302.07 258.12 373.11 440.52 376.55 385.08 343.50
Price/Cash Flow (P/CF)
1,103.19 872.73 826.02 981.92 1,592.10 1,766.25 2,161.57 1,226.81 1,493.67 1,171.81 1,878.08 2,569.07 1,714.77 2,080.17 1,605.89
End of ZBH's Analysis
CIK: 1136869 CUSIP: 98956P102 ISIN: US98956P1021 LEI: - UEI: -
Secondary Listings